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Abstract
Introduction: Accurate evaluation of disease status is very important in treatment of Wegener’s
granulomatosis
Case presentation: A 73-year-old Japanese man presented with chronic sinusitis and otitis media.
He was admitted to our hospital because of bilateral lung nodules. Cytoplasmic antineutrophil
cytoplasmic antibody was negative but his rheumatoid factor was high. He was diagnosed with limited
Wegener’s granulomatosis and received remission induction therapy. His serum rheumatoid factor
level correlated with the Wegener’s granulomatosis state when he experienced a severe infection
and recurrence due to Wegener’s granulomatosis.
Conclusion: We describe a case of Wegener’s granulomatosis in which rheumatoid factor was
helpful for evaluating the therapeutic effect.
Introduction
Wegener’s granulomatosis (WG) is a necrotizing granulo-
matous vasculitis with multisystem involvement. Prog-
nosis, which was once fatal, has been dramatically
improved by treatment with immunosuppressive therapy.
However, an accurate evaluation is necessary to design a
treatment regimen. We describe a case of cytoplasmic
antineutrophil cytoplasmic antibody (c-ANCA) negative
WG in which rheumatoid factor (RF) was useful for
evaluating the disease status.
Case presentation
A 73-year-old Japanese man presented with a one year
history of chronic sinusitis and otitis media that was
unresponsive to otorhinolaryngological therapy. Because
bilateral lung nodules were revealed by chest radiography,
he was admitted to our hospital. He had a history of
pneumoconiosis and cerebral infarction. Physical exam-
ination on admission revealed fever (36.8°C), pulse of 80
beats per minute, and blood pressure of 118/70 mmHg.
The abnormal findings on physical examination were
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remarkable bilateral hearing loss, a saddle-nose deformity,
and rhonchi in the middle left lung field.
Laboratory tests revealed the following: white blood cells
count (WBC) of 7,900/mm3 (68.5% neutrophils, 0.6%
eosinophils, 19.5% lymphocytes); hematocrit, 38.3%;
hemoglobin, 12.7 g/dL; platelet count, 501,000/mm3;
C-reactive protein (CRP), 16.2 mg/dL (normal, < 0.3 mg/
dL); and erythrocyte sedimentation rate (ESR), 108 mm/
hr. Laboratory tests for renal function, including urinalysis,
were normal. c-ANCA was negative but RF was high
(154 IU/ml, latex agglutination assay [normal, < 20 IU/mL]).
Chest radiography and computed tomography (CT)
showed multiple nodules and infiltrates with cavitations
in the bilateral lung (Figure 1A). A bronchoscopic
examination revealed multiple bronchial ulcers with pus
(Figure 2). Biopsies of the bronchial and nasal mucosa
showed nonspecific acute and chronic inflamed tissue
with multinucleated giant cells; however, there was no
evidence of malignancy or tuberculosis in these tissues.
WG (limited disease) was diagnosed despite negative
c-ANCA because our case met the American College of
Rheumatology Diagnosis Criteria of 1990 for WG [1].
He received remission induction therapy with predniso-
lone (PSL) 30 mg/day and trimethoprim-sulfamethoxa-
zole (1:5) 960 mg/day, which improved his symptoms
and laboratory test abnormalities. In particular, there was
a decrease in serum RF level (Figure 3). CT scans revealed
Figure 1. Chest computed tomography scans. Chest computed tomography scans on admission (A), 3 (B), 6 (C), and 12 weeks
(D) after the onset of the induction therapy.
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Figure 2. Bronchoscopy revealed multiple bronchial ulcers with pus.
Figure 3. Clinical course.
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that the multiple lung nodules reduced in size or had
changed to cystic lesions (Figure 1B).
Four weeks after the onset of therapy, his condition was
complicated by severe pyothorax and pneumothorax
(Figure 1C). He was successfully treated with antibiotics
(linezolid and meropenem) and tube thoracostomy
drainage. Although CRP, WBC, and ESR were elevated
during the infection, serum RF level continued to decrease
and CT scans showed a reduction in the size of the
multiple lung nodules. We therefore realized that we were
controlling WG. Because we feared deterioration in patient
condition due to infection, cyclophosphamide 50 mg/day
was added to the induction therapy and PSL was rapidly
tapered to a maintenance dose of 5 mg/day.
Fourteen weeks after the onset of therapy, he complained
of fever again, although there were no signs of infection.
A CT scan revealed an increase in the size of the lung
nodules and slight elevation in serum RF level, suggesting
recurrence of WG, and the PSL was increased to 15 mg/
day. Consequently, his fever abated and serum RF
normalized.
Discussion
WG is themost common of the ANCA-associated vasculitis
diseases. It is clinically characterized by a triad of upper
airway involvement, lower respiratory tract involvement,
and glomerulonephritis [2]. Our patient showed negative
c-ANCA but was diagnosed with WG based on clinical
symptoms, imaging studies, and the microscopic findings
that were not in contradiction with WG.
C-ANCA is highly sensitive (90-95%) in active, systemic
WG, with a specificity of approximately 90% and is usually
but not always correlated with the disease state [3,4].
However, c-ANCA was negative in our case. CRP, ESR, and
WBC are not, of course, specific markers for WG and their
variation can be caused by various stressors such as
infection, drugs, trauma, among others.
InWGpatients with a negative c-ANCAor inwhom c-ANCA
is not correlated with the disease state, the evaluation of
disease status and therapeutic effect are difficult because the
evaluation of WG are based on symptoms, imaging studies,
and non-specific inflammatory markers.
Antibodies to altered g-globulin, so-called RF, occur in
approximately 70% of patients with rheumatoid arthritis
(RA) [5,6]. A high RF level helps confirm the diagnosis of
RA. In addition, RF serum level can be influenced by
treatment and often falls as inflammatory activity
decreases. RF is not specific for RA and is found in many
diseases (e.g.; chronic infections, hepatitis, sarcoidosis,
granulomatous diseases, subacute bacterial endocarditis).
Noritake et al. [7] reported that an elevated RF was
observed in about half of WG cases.
In this case, we predicted that a high RF level was useful for
evaluating the disease state and measured it regularly. As
expected, RF serum level correlated with the WG state. In
particular, when the patient condition was complicated by
a severe infection, the decreasing RF level was extremely
helpful when we decided to taper the PSL.
Even if c-ANCA is positive, there are certain limitations in
evaluating the WG state by c-ANCA. In a series of 106
patients, Kerr et al. [4] reported that c-ANCA titer
temporally correlated with the WG state in only 64% of
patients. In conclusion, there is no definitive marker for
WG and careful and comprehensive observation of
symptoms, laboratory tests, and imaging studies are
most important in all cases. Nevertheless, in cases of WG
with a high RF level, follow-up of this marker is thought to
be of value for evaluating the disease status. Therefore,
further study of WG cases with a high RF level may aid in
determining the usefulness of this classical marker.
Conclusions
We describe a case of WG in which RF correlated with
the disease status and was useful for evaluating the
therapeutic effect.
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